Skip to main content

ERRATUM article

Front. Mol. Biosci., 12 November 2020
Sec. Molecular Diagnostics and Therapeutics
Volume 7 - 2020 | https://doi.org/10.3389/fmolb.2020.596445

Erratum: A DNA Methylation-Based Panel for the Prognosis and Diagnosis of Patients With Breast Cancer and Its Mechanisms

  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
A DNA Methylation-Based Panel for the Prognosis and Diagnosis of Patients With Breast Cancer and Its Mechanisms

by Liu, X.-P., Hou, J., Chen, C., Guan, L., Hu, H.-K., and Li, S. (2020). Front. Mol. Biosci. 7:118. doi: 10.3389/fmolb.2020.00118

Due to a production error, the word “diagnosis,” in the title, was written incorrectly as “dagnosis.”

The correct title is: “A DNA Methylation-Based Panel for the Prognosis and Diagnosis of Patients With Breast Cancer and Its Mechanisms.”

The publisher apologizes for this mistake. The original article has been updated.

Keywords: breast cancer, DNA methylation, prognosis, diagnosis, immune landscape, genomic metrics

Citation: Frontiers Production Office (2020) Erratum: A DNA Methylation-Based Panel for the Prognosis and Diagnosis of Patients With Breast Cancer and Its Mechanisms. Front. Mol. Biosci. 7:596445. doi: 10.3389/fmolb.2020.596445

Received: 19 August 2020; Accepted: 21 August 2020;
Published: 12 November 2020.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

Download